Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Greater Cannabis Company (GCAN) EBIT (2017 - 2026)

Greater Cannabis Company has reported EBIT over the past 6 years, most recently at -$42267.0 for Q4 2022.

  • For Q4 2022, EBIT rose 64.81% year-over-year to -$42267.0; the TTM value through Dec 2022 reached -$177035.0, up 48.41%, while the annual FY2025 figure was -$183005.0, 17.1% down from the prior year.
  • EBIT for Q4 2022 was -$42267.0 at Greater Cannabis Company, up from -$49304.0 in the prior quarter.
  • Over five years, EBIT peaked at $72562.0 in Q1 2018 and troughed at -$200627.0 in Q3 2018.
  • A 5-year average of -$76094.0 and a median of -$75253.0 in 2018 define the central range for EBIT.
  • Biggest five-year swings in EBIT: soared 170.02% in 2018 and later plummeted 830.83% in 2019.
  • Year by year, EBIT stood at -$76168.0 in 2018, then plummeted by 155.66% to -$194730.0 in 2019, then soared by 72.51% to -$53532.0 in 2020, then plummeted by 124.36% to -$120102.0 in 2021, then soared by 64.81% to -$42267.0 in 2022.
  • Business Quant data shows EBIT for GCAN at -$42267.0 in Q4 2022, -$49304.0 in Q3 2022, and -$43034.0 in Q2 2022.